Wikidata

(Q64139891)

English

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Subjects With Atopic Dermatitis (AD)

clinical trial

In more languages

Statements

title
A Multicenter, Open-Label, Single-Group Clinical Trial to Assess the Pharmacokinetics and Safety of Nemolizumab (CD14152) in Adolescent Subjects (12-17 Years) With Moderate-to-Severe Atopic Dermatitis (English)
0 references
medical condition
eczema
0 references
dermatitis
0 references
start time
9 April 2019
0 references
end time
February 2020
0 references
number of participants
20
0 references
minimum age
12 year
0 references
maximum age
17 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64139891&oldid=1858746043"